King, C. E.
Kermode, A.
Saxena, G.
Carvelli, P.
Edwards, M.
Creagh-Brown, B. C. http://orcid.org/0000-0002-4397-1232
Funding for this research was provided by:
LiDCO
Article History
Received: 8 June 2020
Accepted: 29 September 2020
First Online: 22 October 2020
Compliance with ethical Standards
:
: ME has received an honorarium for lecturing from Edwards Lifesciences. He is deputy Chief Investigator of the OPTIMISE II trial, which is funded by Edwards Lifesciences and the NIHR, but does not receive any financial support in this role. He is Chief Investigator of the NIHR-funded FLO-ELA trial, which is supported by Deltex, LidCO and Edwards Lifesciences, who provide cardiac output monitoring equipment to participating trial centres.
: HRA (Health research authority) approval was received 12/July/2019. A favourable ethical opinion was obtained by the south central—Oxford C Research Ethics Committee on the 29/July/2019.
: Informed consent was obtained from all individual participants included in the study.
: Patients signed informed consent regarding publishing their data.